A Study to Compare the Safety and Efficacy of Romosozumab (AMG 785) Versus Placebo in Men With Osteoporosis
Status:
Completed
Trial end date:
2016-04-20
Target enrollment:
Participant gender:
Summary
The study is designed to evaluate if treatment with romosozumab once a month for 12 months
compared with placebo is effective in increasing bone mineral density (BMD) at the lumbar
spine. Additionally, the study will assess the effect of treatment with romosozumab for 12
months compared with placebo on BMD at the femoral neck and total hip.